Stay updated on Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference11%

- Check31 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check45 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.7%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%

- Check60 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. This indicates a shift towards a more streamlined presentation of study status and contact information.SummaryDifference26%

- Check74 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.